Purchasing a drug is becoming more and more expensive for Italians, already grappling with the economic difficulties dictated by the crisis. In fact, in 6 years, between 2005 and 2011, the expenditure per co-payment that citizens have to bear for medicines with a red prescription has increased by almost 160%. What weighs on the pockets of compatriots is the ticket, which rose in total from 515 million curus in 2005 to over 1.3 billion in 2011. In just one year, between 2010 and 2011, the record increase was 34%.
And what emerges from an elaboration on Farmindustria and Aifa data, carried out for Adnkronos Salute by Ketty Vaccaro, Censis Foundation welfare and health manager. The recorded trend clashes with the downward trend in public pharmaceutical expenditure, which fell by 13.7% (from 11.8 billion to 10.2 billion) in the six years examined and by 8.5% (from 11.2 billion to 10 ,2) in the last year analysed. The result is a total expenditure (public and private) that fell by almost 3%: from 19.4 billion in 2005 to 18.9 in 2011.
Not surprisingly, the Italians interviewed by a 2012 Censis survey on which items of private health expenditure had increased "a lot" and "enough" in the last year, answered in the majority (65%) "medicines with co-payment" .
"Even the structural data on the trend of expenditure for drug co-payments - comments Vaccaro - highlights the considerable growth in recent years of this item of expenditure paid by families, which in just one year, from 2010 to 2011, went from just under one billion to I billion and 300 million".
01-08-2013 The Voice of Bankers
Crisis: Federfarma, health poverty on the rise
In central Italy, the request for medicines by families who turn to the Banco Farmaceutico in s
